Anacor Pharma (ANAC) reports partner GlaxoSmithKline (GSK) has voluntarily paused enrollment of ongoing GSK '052 Phase 1, 2 Clinical Trials
Tweet
Share
E-mailGet Alerts ANAC Hot Sheet
Join SI Premium – FREE
Anacor Pharma (Nasdaq: ANAC) reports partner GlaxoSmithKline (NYSE: GSK) has voluntarily paused enrollment of ongoing GSK '052 Phase 1, 2 Clinical Trials
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- HII wins $336M Navy contract for CVN 82 aircraft carrier materials
- Ball Corporation to build new beverage can plant in Uttar Pradesh
Create E-mail Alert Related Categories
Corporate News, FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
